Mergers & Acquisitions Mergers & Acquisitions

Illumina sets aside $453 million for expected EU fine for closing takeover of Grail

By Nicholas Hirst
  • 11 Aug 2022 23:01
  • 11 Aug 2022 23:01
Illumina has set aside almost half a billion dollars to pay a fine from EU merger regulators for closing its acquisition of cancer-testing innovator Grail without receiving approval from the bloc.
The accrual comes after the European Commission formally accused Illumina with breaching EU law (see here), misconduct that can

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Nicholas Hirst

Chief Correspondent

Nicholas covers EU merger review and antitrust investigations for Mlex in Brussels. He previously wrote about EU affairs for Politico Europe, European Voice and PaRR. After earning an LLM in European law from the College of Europe in Bruges, he spent a year working in the competition practice of a leading competition law firm in Brussels 2009-10. He graduated in modern European languages from Oxford University in 2006.

Discover MLex

Stay on top of global regulatory developments

Latest News